Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China

Carcinogenesis

Volumn 26, Issue 2, 2005, Pages 481-486

  Fang, Shumei ^a   Jin, Xia ^a   Wang, Rui ^a   Li, Yan ^a   Guo, Wei ^a   Wang, Na ^a   Wang, Yimin ^a   Wen, Denggui ^a   Wei, Lizhen ^a   Zhang, Jianhui ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; GUANINE; INTERSTITIAL COLLAGENASE; STROMELYSIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INSERTION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; AGED; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SMOKING;

EID: 13844266134     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh327     Document Type: Article

References (37)

1. Egeblad,M. and Werb,Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2 161-174.
2. Brinckerhoff,C.E., Rutter,J.L. and Benbow,U. (2000) Interstitial collagenases as markers of tumor progression. Clin. Cancer Res., 6, 4823-4830.
3. Van Themsche,C., Potworowski,E.F. and St-Pierre,Y. (2004) Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo. Biochem. Biophys. Res. Commun. 315, 884-891.
4. Sternlicht,M.D. and Werb,Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
5. Sternlicht,M.D., Lochter,A., Sympson,C.J., Huey,B., Rougier,J.P., Gray,J.W., Pinkel,D., Bissell,M.J. and Werb,Z. (1999) The stromal proteinase MMP-3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98, 137-146.
6. Ye,S., Dhillon,S., Turner,S.J., Bateman,A.C., Theaker,J.M., Pickering,R.M., Day,I. and Howell,W.M. (2001) Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res., 61, 1296-1298.
7. Rutter,J.L., Mitchell,T.I., Buttice,G., Meyers,J., Gusella,J.F., Ozelius,L.J. and Brinckerhoff,C.E. (1998) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58, 5321-5325.
8. Wyatt,C.A., Coon,C.I., Gibson,J.J. and Brinckerhoff,C.E. (2002) Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Res., 62, 7200-7202.
9. Biondi,M.L., Turri,O., Leviti,S., Seminati,R., Cecchini,F., Bernini,M., Ghilardi,G. and Guagnellini,E. (2000) MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin. Chem., 46 2023-2024.
10. Ye,S., Watts,G.F., Mandalia,S., Humphries,S.E. and Henney,A.M. (1995) Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br. Heart J., 73, 209-215.
11. Ye,S., Eriksson,P., Hamsten,A., Kurkinen,M., Humpries,S.E. and Henney,A.M. (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysis-1 promoter which results in reduced gene expression. J. Biol. Chem., 271, 13055-13060.
12. Hirata,H., Naito,K., Yoshihiro,S., Matsuyama,H., Suehiro,Y. and Hinoda,Y. (2003) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int. J. Cancer, 106, 372-374.
13. Hinoda,Y., Okayama,N., Takano,N., Fujimura,K., Suehiro,Y., Hamanaka,Y., Hazama,S., Kitamura,Y., Kamatani,N. and Oka,M. (2002) Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int. J. Cancer, 102, 526-529.
14. Ghilardi,G., Biondi,M.L., Caputo,M., Leviti,S., DeMonti,M., Guagnellini,E. and Scorza,R. (2002) A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin. Cancer Res., 8, 3820-3823.
15. Kanamori,Y., Matsushima,M., Minaguchi,T., Kobayashi,K., Sagae,S., Kudo,R., Terakawa,N. and Nakamura,Y. (1999) Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res. 59, 4225-4227.
16. Ghilardi,G., Biondi,M.L., Mangoni,J., Leviti,S., DeMonti,M., Guagnellini,E. and Scorza,R. (2001) Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin. Cancer Res., 7, 2344-2346.
17. Zhu,Y., Spitz,M.R., Lei,L., Mills,G.B. and Wu,X. (2001) A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer the susceptibility. Cancer Res., 61, 7825-7829.
18. Zhang,J., Jin,X., Fang,S. et al. (2004) The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastases in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Carcinogenesis, 25, 2519-2524.
19. Miller,S.A., Dybes,D.D. and Polesky,H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
20. Gnasso,A., Motti,C., Irace,C., Carallo,C., Liberatoscioli,L., Bernardini,S., Massoud,R., Mattioli,P.L., Federici,G. and Cortese,C. (2000) Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler. Thromb. Vasc. Biol., 20, 1600-1605.
21. Hanaban,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
22. McCarron,S.L., Edwards,S., Evans,P.R., Gibbs,R., Dearnaley,D.P., Dowe,A., Southgate,C., Easton,D.F., Eeles,R.A. and Howell,W.M. (2002) Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res., 62, 3369-3372.
23. Kim,Y.J., Lee,H.S., Im,J.P. et al. (2003) Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp. Mol. Med., 35, 196-202.
24. Niki,T., Kohno,T., Iba,S. et al. (2002) Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am. J. Pathol., 160, 1129-1141.
25. Zhang,J.H., Li,Y., Wang,R., Wen,D.G., Sarbia,M., Kuang,G., Wei,L.Z., He,M., Zhang,L.W. and Wang,S.J. (2003) Association of Cyclin D1 (G870A) Polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a Northern Chinese population. Int. J. Cancer, 105, 281-284.
26. Niki,T., Kohno,T., Iba,S. et al. (2002) Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am. J. Pathol., 160, 1129-1141.
27. Wu,X., Zhao,H., Wei,Q., Amos,C.I., Zhang,K., Guo,Z., Qiao,Y., Hong,W.K. and Spitz,M.R. (2003) XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis, 24, 505-509.
28. Liang,G., Xing,D., Miao,X., Tan,W., Yu,C., Lu,W. and Lin,D. (2003) Sequence variations in the DNA repair gene XPD and risk of lung cancer in a Chinese population. Int. J. Cancer, 105, 669-673.
29. Schutz,A., Schneidenbach,D., Aust,G., Tannapfel,A., Steinert,M. and Wittekind,C. (2002) Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung. Tumour Biol., 23, 179-184.
30. Thomas,P., Khokha,R., Shepherd,F.A., Feld,R. and Tsao,M.S. (2000) Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer. J. Pathol., 190, 150-156.
31. Michael,M., Babic,B., Khokha,R., Tsao,M., Ho,J., Pintilie,M., Leco,K., Chamberlain,D. and Shepherd,F.A. (1999) Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer. J. Clin. Oncol., 17, 1802-1808.
32. Zhang,J., Cui,Y., Kuang,G. et al. (2004) Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Carcinogenesis, 25 2479-2485.
33. Yu,C.Y., Pan,K.F., Xing,D.Y., Liang,G., Tan,W., Zhang,L. and Lin,D. (2002) Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res., 62, 6430-6433.
34. Curran,S. and Murray,G.I. (1999) Matrix metalloproteinases in tumor invasion and metastasis. J. Pathol., 189, 300-308.
35. Werb,Z. (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell, 91, 439-442.
36. Lukashew,M.E. and Werb,Z. (1998) ECM signaling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol., 8, 437-441.
37. Giannelli,G., Falk-Marzillier,J., Schiraldi,O., Stetler-Stevenson,W.G. and Quaranta,V. (1997) Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science, 277 225-228.